Neuroendocrine prostate cancer (NEPC) is the most aggressive form of prostate cancer, responsible for up to 20% of therapy-resistant cases and associated with rapid disease progression. It is ...

Assembled entire laboratory infrastructure required for advanced mass spectrometry and developed proteomic technologies for analyzing neurological and neuroendocrine signaling. • Obtained first human ...

Treatments for COPD, psoriasis, and neuroendocrine tumors, as well as a next-generation COVID-19 vaccine are under review.